William Blair Investment Management LLC Sells 136,288 Shares of Inspire Medical Systems, Inc. $INSP

William Blair Investment Management LLC trimmed its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 10.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,161,285 shares of the company’s stock after selling 136,288 shares during the period. William Blair Investment Management LLC owned 4.00% of Inspire Medical Systems worth $107,105,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Y Intercept Hong Kong Ltd raised its stake in shares of Inspire Medical Systems by 553.1% during the third quarter. Y Intercept Hong Kong Ltd now owns 99,049 shares of the company’s stock worth $7,349,000 after buying an additional 83,883 shares during the last quarter. Regal Partners Ltd bought a new stake in shares of Inspire Medical Systems during the third quarter worth approximately $7,547,000. Illinois Municipal Retirement Fund raised its stake in shares of Inspire Medical Systems by 262.0% during the third quarter. Illinois Municipal Retirement Fund now owns 25,424 shares of the company’s stock worth $1,886,000 after buying an additional 18,400 shares during the last quarter. State of New Jersey Common Pension Fund D raised its stake in shares of Inspire Medical Systems by 79.9% during the third quarter. State of New Jersey Common Pension Fund D now owns 23,216 shares of the company’s stock worth $1,723,000 after buying an additional 10,311 shares during the last quarter. Finally, Rheos Capital Works Inc. raised its stake in shares of Inspire Medical Systems by 124.0% during the fourth quarter. Rheos Capital Works Inc. now owns 117,400 shares of the company’s stock worth $10,828,000 after buying an additional 65,000 shares during the last quarter. 94.91% of the stock is owned by institutional investors.

Inspire Medical Systems Stock Down 2.1%

Shares of INSP stock opened at $43.79 on Friday. The firm has a fifty day moving average of $51.61 and a 200-day moving average of $76.29. Inspire Medical Systems, Inc. has a 12-month low of $39.61 and a 12-month high of $147.66. The company has a market capitalization of $1.26 billion, a price-to-earnings ratio of 9.75, a P/E/G ratio of 4.53 and a beta of 0.83.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings data on Monday, May 4th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.38. Inspire Medical Systems had a net margin of 14.33% and a return on equity of 10.35%. The company had revenue of $204.58 million during the quarter, compared to the consensus estimate of $200.04 million. During the same quarter in the prior year, the firm earned $0.10 earnings per share. The firm’s revenue was up 1.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. On average, equities analysts expect that Inspire Medical Systems, Inc. will post 0.91 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Zacks Research downgraded shares of Inspire Medical Systems from a “hold” rating to a “strong sell” rating in a research note on Wednesday, May 13th. Wells Fargo & Company lowered their target price on shares of Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 5th. Robert W. Baird lowered their target price on shares of Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating for the company in a research note on Tuesday, May 5th. Truist Financial lowered their target price on shares of Inspire Medical Systems from $64.00 to $50.00 and set a “hold” rating for the company in a research note on Tuesday, May 5th. Finally, Piper Sandler downgraded shares of Inspire Medical Systems from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $85.00 to $55.00 in a research note on Tuesday, May 5th. Four equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, Inspire Medical Systems currently has a consensus rating of “Hold” and an average target price of $81.84.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.